Hm Payson & CO Teladoc Health, Inc. Transaction History

Hm Payson & CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$15.57 - $22.1 $498 - $707	-32 Reduced 24.24%	100 $2,000
Q1 2023 Apr 18, 2023	SELL	$22.27 - $33.2 $1,113 - $1,660	-50 Reduced 27.47%	132 $3,000
Q2 2022 Aug 15, 2022	SELL	$28.63 - $75.86 $1,431 - $3,793	-50 Reduced 21.55%	182 $6,000
Q1 2022 May 12, 2022	SELL	$50.79 - $95.08 $22,195 - $41,549	-437 Reduced 65.32%	232 $17,000
Q4 2021 Feb 15, 2022	SELL	$87.43 - $154.29 $165,067 - $291,299	-1,888 Reduced 73.84%	669 $61,000
Q3 2021 Nov 30, 2021	SELL	$125.92 - $164.64 $88,144 - $115,247	-700 Reduced 21.49%	2,557 $324,000
Q2 2021 Aug 17, 2021	BUY	$132.71 - $192.38 $92,764 - $134,473	699 Added 27.33%	3,257 $542,000
Q1 2021 Jun 15, 2021	BUY	$171.3 - $294.54 $55,672 - $95,725	325 Added 14.55%	2,558 $465,000
Q4 2020 Mar 10, 2021	BUY	$172.44 - $231.8 $100,187 - $134,675	581 Added 35.17%	2,233 $447,000
Q3 2020 Dec 21, 2020	BUY	$183.75 - $249.42 $297,675 - $404,060	1,620 Added 5062.5%	1,652 $362,000
Q2 2020 Aug 13, 2020	BUY	$139.1 - $204.94 $4,451 - $6,558	32 New	32 $6,000

454

125M

4.83M

4.52M

Ticker TDOC
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 162,196,000
Market Cap $1.54B
Description
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health cond...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.